Effect of Sleep Extension on Body Weight and Learning in Children (More2Sleep)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-12
SponsorUniversity of Copenhagen

About this trial

More2Sleep is a randomized, controlled, parallel trial with two groups (sleep extension vs control) including 142 school-aged children (6-12 years) who have a BMI above average, defined as age- and sex-specific BMI Z-score above zero using WHO reference standards, and habitually sleep for ≤ 9 h/night. Data will be collected before and after a 3-month sleep extension intervention, and after a 6-month follow-up (at months 0, 3, and 9). The collection of data is mainly related to the main study. However, some optional examinations will be conducted on a first come, first serve basis, consisting of substudy-I (metabolic mechanisms, n=60) and substudy-II (learning mechanisms, n=142).

The primary objective is to assess the effects of sleep extension by \~45 min/night, achieved by going to bed 60-90 min earlier, on adiposity and learning ability in school-aged children who have a BMI for age and sex above average, and sleep less than recommended for their age.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age: 6-12 years old (inclusive range).

Weight status: having a BMI above average, defined as an age- and sex-specific BMI Z-score above zero using reference standards from the WHO.

Sleep duration: sleeping ≤9 h/night on the basis of sleep diaries filled in by the children's parents, based on recommendations by the American Academy of Sleep Medicine and the Sleep Health Foundation.

Disqualifiers

Any genetic, neurological, endocrinological or psychiatric condition that affects growth, metabolism, eating behaviors, cognitive function, or body weight (for example: dwarfism, epilepsy, attention deficit hyperactivity disorder, head trauma, β-thalassemia, hypothyroid-ism, hyperthyroidism, type I diabetes).

Any sleep-related disorder (for example: obstructive sleep apnea, parasomnias, narcolepsy, restless leg syndrome).

Regular use of prescribed or over-the-counter medications that influence study outcomes.

Irregular school schedule.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Sleep extension

    Behavioral

    The sleep extension group will receive a behavioral intervention focusing on parents putting their children to bed earlier by 60-90 minutes. Previous studies have found this change in daily sleeping routine to be feasible and to result in 40-45 min more actual sleep. Children and their parents will receive a behavioral intervention consisting of 6 sessions, including both in-person and virtual sessions, which will be scheduled based on the family's availability and to accommodate practicalities, e.g., potential sickness or cancellations. The first two sessions will occur at the beginning of the study. These initial sessions will focus on effective behavioral strategies to enhance sleep time, including goal setting (e.g., bedtimes and wake-up times), problem-solving and preplanning, stimulus control (i.e., sleep hygiene recommendations), and positive reinforcement. Subsequent sessions will be planned with the families to occur regularly during the 12-week intervention.

Treatment groups

142 Participants
are divided into 2 treatment groups
Group A: Sleep extensionExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

BMI Z-score

BMI (in kg/m\^2) will be calculated from weight and height (secondary outcomes), and the age- and sex-specific BMI Z-score (in units of standard deviation from the reference population mean) will be computed using international (WHO) data

Time frame
Assessed at months 0, 3 and 9
2

Learning ability: skill learning

Skill learning ability will be measured as motor memory assessed as 24h retention after skill practice - I.e. total within and between session effect (range: from "low" = 0 to "high" = 100, unitless)

Time frame
Assessed at months 0 and 3
3

Learning ability: Explicit memory

Explicit memory assessed as 24h retention after word list memory encoding - I.e. total within and between session effect. Number of correctly recalled words in a 2-minute standardized task (range: from 0 to 20)

Time frame
Assessed at months 0 and 3

Secondary outcomes

1

Body fat percent

Body fat in % of total body mass (total fat mass divided by total body weight) will be measured by a whole-body dual-energy X-ray absorptiometry (DXA) scan

Time frame
Assessed at months 0, 3 and 9
2

Total fat mass (FM)

Body FM (in grams) will be measured by a whole-body dual-energy X-ray absorptiometry (DXA) scan

Time frame
Assessed at months 0, 3 and 9
3

Total lean mass (LM)

Body LM (in grams) will be measured by a whole-body dual-energy X-ray absorptiometry (DXA) scan

Time frame
Assessed at months 0, 3 and 9
4

Bone mineral content (BMC)

BMC (in grams) will be measured by a whole-body dual-energy X-ray absorptiometry (DXA) scan

Time frame
Assessed at months 0, 3 and 9

Other outcomes

1

Health-related quality of life: child-reported

The total summary score of health-related quality of life (from 50 to 250), and sub-scale scores (from 10 to 50) of physical well-being, psychological well-being, autonomy and parent relation, peers and social support, and school environment, will be assessed by KIDSCREEN 27 questionnaire

Time frame
Assessed at months 0, 3 and 9
2

Health-related quality of life: parent-reported

The Health Related Quality of Life score (from 0 to 100), Physical Health Summary score (from 0 to 100) and Psychosocial Health summary score (from 0 to 100) will be assessed by the Pediatric Quality of Life inventory (PedsQL)-Parent report (separate version for 6-7 y and 8-9 years olds)

Time frame
Assessed at months 0, 3 and 9
3

Mental health: parent-reported

The total difficulties score (from 0 to 40) of the Strengths and Difficulties Questionnaire, as well as sub-scale scores (from 0 to 10) of emotional symptoms, conduct problems, hyperactivity/inattention, relationship problems and prosocial behavior

Time frame
Assessed at months 0, 3 and 9
4

Parental Stress Scale: parent-reported

Perceived parental stress (from 18 to 90) will be assessed by the Parental Stress Scale questionnaire

Time frame
Assessed at months 0, 3 and 9

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Copenhagen

Lead sponsor

Novo Nordisk Foundation (NNF)

Collaborator

Faculty of Health, Medicine and Life Sciences, Maastricht University

Collaborator

Center for Obesity Research & Education, Temple University

Collaborator

Danish Research Centre for Magnetic Resonance

Collaborator

University of Southern Denmark

Collaborator